throbber
Volume 7 Number 4 1979
`
`Nucleic Acids Research
`
`Separation of o6go-RNA by reverse-pblse HPLC
`
`Gloria D.McFarland and Philip N.Borer
`
`Department of Chemistry, Univeni.ty of California, Irvine, CA 92717, USA
`
`Received 22 June 1979
`
`ABSTRACT
`
`A rapid and highly reproducible chromatographic technique
`has been developed for analysis and purification of complex
`mixtures of oligoribonucleotides. The method utilizes a column
`of microparticulate porous silica beads fully derivatized with
`octadecylsilyl groups. The column is eluted with gradients in
`acetonitrile/water/ammonium acetate pumped at pressures of
`1500-3000 psi. Most separations are completed in 5-15 min. with
`usually better than 11. reproducibility of absolute retention times
`and about 0.1% reproducibility of relative retention times. A
`single column accomplishes separations of mononucleosides,
`mononucleotide&, and larger oligomers through at least 20-mers.
`The absolute detection limit is ~1 pmole of base though most of
`the analytical separations described use ~1 nmole.
`In favorable
`circumstances it is possible to use the analytical columns to
`purify ~1 mg of an oligonucleotide in a single 10-30 min. elu(cid:173)
`tion.
`
`INTRODUCTION
`
`Most oligonucleotide syntheses have depended heavily on low(cid:173)
`pressure liquid chromatography by ion-exchange. 1- 5 Recent
`improvements in separation methods involve high-pressure ion(cid:173)
`exchange,6 RPC-5 (which combines ion-exchange and reverse-phase
`modes) , 7- 12 and reverse-phase chromatography on covalently bonded
`silica-octadecylsilane (ODS) columns where Khorana and his co(cid:173)
`workers have made considerable progress in separating derivatized
`and underivatized DNA oligomers. 13 All but the latter suffer
`from the disadvantage that the long elution times (30 min. to
`several days) severely limit their analytical usefulness. A
`major objection to RPC-5 is the current lack of a stable
`commercial supply and severe irreproducibility between batches. 8
`Additionally RPC-5 cannot be used to separate very short oligomers
`
`C Information Retrieval Limited 1 Falconberg Court London W1 V 5FG England
`
`1067
`
`1
`
`MTX1015
`
`

`

`Nucleic Acids Research
`
`because the non-covalently bound coating bleeds off the beads at
`the low salt concentrations required. This problem is not
`encountered with the bonded-phase ODS columns.
`Prepacked microparticulate silica-ODS columns such as those
`used in our work are available from several manufacturers. We
`have used four different ''Microbondapak Cl8" columns from Waters
`Corporation over a period of three years and find excellent
`reproducibility from column to column. A similarly formulated
`column from Altex Corporation provided different chromatographic
`patterns but would be suitable for separations like those de(cid:173)
`scribed here. A stable supply of these columns is assured
`because the manufacturers sell thousands each year due to their
`wide use for separations in organic chemistry.
`Reverse-phase separations are based on the exclusion of a
`solute containing lipophilic components from a polar mobile
`phase. When the mobile phase is made less polar partition no
`longer favors the stationary phase for the least lipophilic
`molecules; solutes elute from the column in order of decreasing
`polarity.
`In order to decrease separation time and band(cid:173)
`broadening it is often useful to perform gradient elution where
`the solvent mixture is made progressively less polar.
`In our
`situation the acetonitrile content is increased in a solvent
`that is otherwise composed of 1% ammonium acetate in water.
`Methanol is also used in place of acetonitrile by many chemists;
`we prefer acetonitrile for two reasons:
`(1) its vapor pressure
`is much lower which reduces problems with bubble formation by
`cavitation at high pumping rates, and (2) the viscosity of aceto(cid:173)
`nitrile-water mixtures is much lower than corresponding methanol(cid:173)
`water mixtures allowing columns to be operated at lower pressures
`thus decreasing wear on pumps and columns. Acetonitrle is cur(cid:173)
`rently 3 times more expensive than methanol but one gallon of
`acetonitrile suffices for 300 hours of continous chromatography
`using our system. Thus solvent cost is a rather small factor.
`
`MATERIALS AND METHODS
`HPLC System. A modular HPLC system was purchased from Waters
`Corporation (Milford, Massachusetts) including two model 6000A
`high pressure pumps, a model 660 solvent programmer, a model 440
`
`1068
`
`2
`
`

`

`Nucleic Acids Research
`
`uv absorbance monitor, and a model U6K sample injector. The
`outlet of a 30 em x 0. 39 em ID "Microbondapak Cl81' column was
`connected to the uv monitor and preceded by a guard column, cut
`from a length of a 2 mm ID "Corasil Cl8" column (also from Waters),
`which was connected to the injector. The guard column was cut
`to a length of 2 em with a tubing cutter being careful to prevent
`any loss of packing material. The guard columns had to be re(cid:173)
`placed at 6-8 week intervals when the normal operating pressure
`at 3 ml/min rose to ~3000 psi. A single 2 mm ID ~ 61 em Corasil
`Cl8 column can provide at least 20 guard columns. All column con(cid:173)
`nections were made with (0.009 in ID) stainless steel tubing and
`zero-dead-volume fittings (Parker-Hannifin, Irvine, California).
`The total void volume of the system was 1.24 ml from injector to
`uv detector.
`Solvents. Solvents had to be maintained at a very high
`degree of purity. Deionized water was further purified through
`a ''11illi-Q" (Millipore Corporation) system consisting of a pre(cid:173)
`filter, an activated charcoal filter, two ion-exchange cartridges,
`and a 0.22 micron final filter. To maintain high-purity water
`the system was allowed to recirculate at least 15 min before
`drawing off water; no more than 6~ should be removed before allow(cid:173)
`ing another 15 min of recirculation. Because gradient elution
`is frequently performed over a range of only 2-3% in acetonitrile
`concentration it is absolutely necessary to prepare solvents in
`a uniform manner.
`10% ammonium acetate (Mallinckrodt AR grade)
`was prepared by dissolving the entire contents of a ~ lb bottle
`in water, adjusting to pH= 5.9 with acetic acid and diluting to
`1.11 ~. then filtering through a 0.45 micron filter (Millipore(cid:173)
`HA) . Acetonitrile (Baker HPLC grade) was filtered through a
`Fluoropore (Millipore-FH) filter. Solutions are prepared by
`diluting appropriate amounts of CH3CN and 10% AmOAc to 9.00 t
`according to the chart
`on the following page. Solution a
`(or a') is supplied to the low concentration pump, called
`pump A; likewise b (or b') is supplied to the high side, called
`pump B. Most elutions were performed with solutions a and b,
`covering a range from 2% to 12% CH3CN. The model 660 programmer
`adjusts the pumping rates of pumps A and B to maintain a constant
`total flow rate and gives a readout of the portion of flow
`
`1069
`
`3
`
`

`

`Nucleic Acids Research
`
`Solution
`
`'%.CH3CN
`
`CH3CN(m1)
`
`10'1. AmOAc(mf.)
`
`a
`
`b
`
`a'
`
`b'
`
`2
`
`12
`
`1
`
`11
`
`180
`
`1080
`
`90
`
`990
`
`880
`
`790
`
`890
`
`800
`
`provided by pump B as "'1.B". Selection of a narrow range in
`CH3CN concentration allows greater accuracy in reproducing solvent
`composition and a 10'1. range between solutions a and b (or a' and
`b') allows easy computation of absolute CH3CN concentration at any
`time during the elution by the formula '1.B/10 + A • CH3CN con(cid:173)
`centration; A= 2% for solution a and 1% for a'.
`In the chrom(cid:173)
`atograms shown in Figs. 1-3 solvent strength increased linearly
`with time from t = o until the end of the gradient program; there(cid:173)
`after solvent composition and flow rate remained constant until
`all peaks were eluted.
`In certain separations (not shown) con-
`vex or concave gradients were adopted to optimize resolution of
`components. Flasks containing "'200 ml of pure CH3CN and "-11
`volumes of a and b were degassed in an ultrasonic bath at the
`beginning of each day. Solvent lines, pumps, and columns were
`stored in pure CH3CN and air bubbles carefully cleared from sol(cid:173)
`vent lines and pumps at the beginning of each day. Solvent switch(cid:173)
`over from pure CH3CN to solutions a and b was accomplished by
`gradient programs of 5 min at 3 mi./min.
`Sample Injection. Samples were always clarified by centri(cid:173)
`fugation if cloudiness was apparent. Syringes were purchased
`from Hamilton Corporation supplied with a 26S ga, 22° bent
`point needle designed to prevent damage to the U6K injector.
`Sample sizes smaller than 25 111 were tnjected without regard to
`chloride ion concentration but large samples and solvents con-
`
`1070
`
`4
`
`

`

`Nucleic Acids Research
`
`taining halide ions were avoided because of chemical attack on
`stainless steel. Following each nm a 3 m.l "bomb" of solution
`b (programmer set to 100%B) was run into the column to elute
`any strongly adsorbed species before returning to solvent
`conditions appropriate for the next run. The next sample can(cid:173)
`not be loaded onto the U6K injector until the bomb has cleared
`the sample loop and the column restored to initial conditions
`for the next nm.
`Isolation of Purifie'd Components. The analytical columns can
`be used for semi-preparative purifications in many instances.
`Acetonitrile and most of the water is removed from selected frac(cid:173)
`tions in a flash evaporator. Samples are redissolved in water
`such that the ammonium acetate concentration is 10% or less,
`frozen, and lyophilized to remove ammonium acetate. Dialysis
`or desalting on polyacrylamide gels is usually not necessary.
`Oligonucleotide Preparation. Nucleosides, nucleotides,
`dinucleoside monophosphates, poly U, and poly C were purchased
`from Sigma Chemical Corporation; poly A from Miles Biochemicals;
`alkaline phosphatase (calf intestine) from Boehringer-Mannheim.
`Primer-independent polynucleotide phosphorylase was purchased
`from P-L Biochemicals and made primer-dependent by limited
`trypsin digestion. 14
`Homologous series, oligo An• oligo en, and oligo Un, were
`prepared by alkaline hydrolysis at 60°C (3.3 mM poly X, 1.0 M KOH,
`100 pi total volume). Hydrolysis was stopped (at times indicated
`in the figure legends) by addition of 12 pi 10 M HCi04 and
`incubated at pH ~2 to eliminate 2'-3'-cyclic phosphates (60° for
`10 min) . Terminal phosphates were removed by incubation
`overnight at 37°C with alkaline phosphatase (300 pg/mi) after
`adding 6 pi 2M HEPES buffer and adjusting to pH=7. 5 with -v2pi
`10 M KOH. Solid KCi04 was removed by centrifugation. Oligo(cid:173)
`nucleotide preparations by primer-dependent polynucleotide
`2-5
`phosphorylase followed in methods described earlier.
`
`RESULTS AND DISCUSSION
`Dbt'ucleos'ide monophosphates. Several general features of
`reverse-phase HPLC separations of oligo-RNA are shown in Fig. 1.
`
`1071
`
`5
`
`

`

`Nucleic Acids Research
`
`A254
`
`.03
`
`.02
`
`.0 I
`
`e.a,7
`
`2 • •
`
`8
`
`1011
`12
`
`0~ u
`\....) "-Ju u
`.
`
`0
`
`5
`
`Time (min)
`
`10
`
`IS
`
`~· '
`
`\.
`
`16
`
`15
`
`Figure 1. 16 dinucleoside monophosphates separated by a 15 minute
`linear CH 3CN gradient, from 2% to 8% (using solvents a and b),
`at 3 ml/~n flow rate. The numbered peaks are identified in
`Table I.
`
`All 16 of the dinucleoside monophosphates were loaded onto the
`column c~o.5 nmole each) and separated by a 15 minute linear
`gradient covering a range from 2% to 8% CH3CN (Solvents a and b,
`gradient 0-+60%B). Elution parameters for this separation:
`peak identities, retencion times (tR), and retention times relative
`to ApA are collected in Table I along with parameters for a simi(cid:173)
`lar 15 minute 2% to 11% CH3CN program. The figure shows that
`most of the 16 components are clearly separated in this single
`15 minute run; further illustrations of the tremendous resolving
`power of this system are found in comparing the isomeric molecules,
`eg. ApC and CpA which elute 2.5 min. apart. It is usually true
`that e-rich oligomers elute first, followed by U-rich, G-rich,
`then A-rich oligomers in that order; CpC elutes first and ApA last.
`The arrangement of data in Table I follows this order, the XpC
`group first (X is any of the four bases), followed by the XpU,
`XpG, and XpA groups. Within each group it is seen that as X
`changed through C, U, G, and A there is a 1.5 to 3.5 min. inter(cid:173)
`val in tR. This interval is fairly constant for a specific 5'(cid:173)
`nucleotidyl base, eg. the difference in tR between 5'-G and
`
`1072
`
`6
`
`

`

`Nucleic Acids Research
`
`TABLE I
`
`Elution Parameters for 16 Dinucleoside Monophosphates
`Separated by Two Different 15 minute Linear Gradients, at
`
`3 ml/min Flow Rate, Using Solvents a and b
`
`0+60t B
`(2t to 8t CH 3CN)
`
`0+90t B
`(2t to llt CH 3CN)
`
`Number
`(Fig. 1)
`
`tR
`(min:sec)
`
`XpY
`
`tf Relative to
`A • 1. 00
`p
`
`tR
`(min:sec)
`
`tR Relative
`to ApA • 1.00
`
`CpC
`
`ope
`
`u
`~ GpC
`
`1
`
`4
`
`7
`
`3:42
`
`5:26
`
`6:50
`
`ApC
`
`12
`
`10:32
`
`CpU
`
`0 OpO
`llo
`~
`
`GpO
`
`2
`
`5
`
`9
`
`4:30
`
`6:45
`
`9:28
`
`0.236
`
`0.347
`
`0.436
`
`0.672
`
`0.287
`
`0.431
`
`0.604
`
`3:56
`
`5:37
`
`6:59
`
`9:55
`
`4:48
`
`6:45
`
`8:40
`
`11:42
`
`0.276
`
`0.394
`
`0.490
`
`0.696
`
`0.337
`
`0.474
`
`0.608
`
`ApO
`
`14
`
`12:30
`
`0.798
`
`CpG
`
`OpG
`
`l.'l
`llo
`~ GpG
`
`ApG
`
`CpA
`
`8 OpA
`
`~ GpA
`
`ApA
`
`3
`
`6
`
`10
`
`15
`
`8
`
`11
`
`13
`
`16
`
`5:00
`
`6:45
`
`9:50
`
`13:00
`
`8:01
`
`10:11
`
`12:10
`
`15~40
`
`0. 319
`
`0.431
`
`0.628
`
`0.830
`
`0.512
`
`0.650
`
`o. 777
`
`1.000
`
`5:10
`
`6:48
`
`9:04
`
`11:58
`
`7:50
`
`9:15
`
`11:16
`
`14:15
`
`0.821
`
`0.363
`
`0.501
`
`0.636
`
`0.840
`
`0.550
`
`0.649
`
`0.791
`
`1.000
`
`5'-A is 3:20±20 sec for each of the four groups. Such trends may
`be useful in adapting this analytical system to sequencing
`oligonucleotides.
`There is some variation in absolute retention times from day
`to day but retention times relative to tR • 1.000 for ApA are
`reproducible to ±0.020 or better. (±20 sec). Within runs on a
`
`1073
`
`7
`
`

`

`Nucleic Acids Research
`
`single day these relative tR values are usually reproducible to
`±0.005 (±5 sec). Since ApA usually elutes later than anything
`else it is a convenient reference for expressing relative retention.
`Nucleosides and nucleoside monophosphates. Table II shows
`the elution parameters for several monomeric constituents of RNA.
`The general trend of C, U, G, A in order of elution is again
`observed. We have exaudned the nucleosides (N), nucleoside-5 1 -
`phosphates (pN), nucleoside-3'-phosphates (Np), nucleoside-2':
`3'-cyclic phosphates (Np>), and nucleoside-3':5'-cyclic phosphates
`(cpN). We have not tabulated data on nucleoside-5'-diphosphates
`(ppN), triphosphates (pppN) and 2'-monophosphates (Np') but
`elution order follows this scheme: pppN, ppN, pN, Np, Np', Np>,
`N, cpN. We are usually unable to utilize the small difference in
`retention between pppN, ppN, and pN because of their close
`proximity to the void volume of the column; this is especially
`true for the pyrimidine nucleotides. The difference between the
`tR values of N and cpN are also usually small. Retention of
`the pN, Np, and Np' species are quite sensitive to the pH of
`the solvent so care should be taken to reproducibly prepare
`solvents with pH = 5.9.
`Homolgous series. Elution profiles of homooligonucleotide
`mixtures are presented in Figure 2. Panel a shows the separation
`of (Cp)nC oligomers, panel b (Up)n U oligomers, and (Ap)n A
`oligomers in panel c. The separations give excellent resolution
`of oligomers out through at least n = 10.
`In certain instances
`we have turned separation parameters to give resolution of n = 25
`from n = 26 oligomers and see no reason wny the resolution cannot
`be extended to longer oligomers. An oligomer with n • 10, eg.
`(Ap) 1oA, is a polyanion with 10 negative charges; one might sup(cid:173)
`pose that this would be such a highly polar molecule that it would
`not be retarded on a reverse-phase column.
`In fact, however,
`(Ap) 10A is retarded more than (Ap) 9A, so the separation ~;t be
`based upon the number of lipophilic substituents (bases); 4
`there
`is no need to resort to ion-exchange or expensive ion-pairing
`reagents.
`The amount of time required for a particular separation is
`directly related to the complexity of the mixture being analyzed.
`In the case of these homologous series, where up to twenty com-
`
`1074
`
`8
`
`

`

`Nucleic Acids Research
`
`TABLE II
`
`Elution p·arame·t·e·r·s· fo·r· Wucleosides and Nucleoside Monophosphatea.
`The following conditions were used: 16 minute linear gradient,
`from 0 to 90\ B, using solvents a and b (2\ to 11\ CH 3CN) at
`3 ml/min flow rate.
`tf Relative
`tR
`(min: sec)
`to pA • 1.00
`
`z
`llo
`
`pC
`
`pU
`
`pG
`
`pA
`
`Cp
`
`Up
`llo z Gp
`
`Ap
`
`Cp>
`" llo Up>
`z
`Gp>
`
`Ap>
`
`c
`z u
`G
`
`A
`
`cpC
`
`z cpU
`llo
`u
`cpG
`
`cpA
`
`1:28
`
`1:16
`
`1:32
`
`1:39
`
`1:28
`
`1:34
`
`2:04
`
`3:50
`
`1:22
`
`1:37
`
`3:03
`
`5:37
`
`1:55
`
`2:15
`
`4:19
`
`7:24
`
`2:31
`
`2:59
`
`4:07
`
`7:10
`
`0.122
`
`0.106
`
`0.128
`
`0.138
`
`0.122
`
`0.130
`
`0.161
`
`0.296
`
`0.113
`
`0.132
`
`0.249
`
`0.460
`
`0.152
`
`0.178
`
`0.341
`
`0.585
`
`0.206
`
`0.243
`
`0.335
`
`0.581
`
`1075
`
`9
`
`

`

`Nucleic Acids Research
`
`nao
`
`A~
`
`a
`
`2
`
`II
`
`4
`
`!
`
`2
`
`(C~2 C oligomers
`n
`120 sec hydrolysis
`60 min linear gradient
`1% to 4.3% CH3CN
`(solvents a' and b')
`
`.10
`
`0
`0
`
`A254
`
`n•O
`
`~ U oligomers
`n
`60 sec hydrolysis
`.I
`30 min linear gradient
`2% to 1% CH3CN
`(solvents a and b)
`
`0
`0
`A254
`
`03
`
`.. 0
`
`~n A oligomers
`180 sec hydrolysis
`30 min linear gradient02
`7% to 8.5% CH3CN
`(solvents a and b)
`
`Dl
`
`2
`
`II
`
`4
`
`4
`
`!
`
`60
`
`b
`
`c
`
`0
`0
`
`20
`TIME {min)
`
`30
`
`Figure 2. Elution profiles of homologous series. Each series was
`prepared by alkaline hydrolysis of the appropriate homopolymer.
`All elutions at 2 ml/min flow rate.
`
`1076
`
`10
`
`

`

`Nucleic Acids Research
`
`ponents have been separated in a single run (eg. (Cp)nC series),
`we have resorted to separations as long as 60 minutes in order to
`increase the resolving power. of the system, However, in sit-
`uations where only a few components are of interest, as it
`frequently occurs in practice, 10 to 15 minutes is sufficient;
`a 15 minute linear gradient from 1% to 3. 8% CH3CN at 3 ml/min
`flow rate will give baseline separation of C through (Cp) 4c
`in the (Cp)nC series.
`Block Copolymers. A coumon result of an oligonucleotide
`synthesis with primer dependent polynucleotide phosphorylase
`is a "block" addition product with a block of identical bases
`at the 3'-end and a primer molecule of defined sequence at the
`5'-end of the molecule; the primer may be as short as a dinucleo(cid:173)
`tide. Examples of the separation problems encountered are il(cid:173)
`lustrated in Figure 3 with molecules of the type, ApG(pX)n, where
`the primer is ApG. Separation of the ApG(pA)n (Figure 3a) and
`ApG(~U)n (Figure 3b) oligomers proceeds nicely with clear reso(cid:173)
`lution of products with n = 1-3 (the usual range of interest) in
`5-10 min. However, ApG(pC)n (Figure 3c) oligomers do not separate
`following the expected pattern, i.e. in order of increasing
`chain length.
`Instead, the reverse order is observed, in this
`case as well as in a number of other C righ oligomer series, under
`some separation conditions. The polyanion character of these
`molecules then must override the affinity of the lipophilic
`moities for the stationary phase under theae solvent conditions
`and the least charged oligomers are retarded most.
`Only at relatively low CH3CN concentrations do (Cp)nC
`oligomers elute in order of increasing chain length as in
`Figure 2. To obtain these results it is necessary to use solvents
`a' and b' which cover a range of CH3CN concentrations starting at
`1%; the use of solvents a and b (2% and 12% respectively) results
`in separations where the order of elution is reversed, as in
`Figure 3c, or even some in which no simple pattern of elution is
`discernible.
`Throughout all the separations described in this paper, pH
`has remained constant. However, it might prove useful in some
`difficult separations to lower the pH of the solvents to 3
`in order to positively charge adenosine and cytidine residues
`
`1077
`
`11
`
`

`

`Nucleic Acids Research
`
`.10
`
`a
`
`ApG(pA)n series
`10 min linear gradient
`6% to 8% CH3CN
`
`ApG(pU)n series
`10 min linear gradient
`6% to 7% CH3CN
`
`ApG(pC)n series
`10 min linear gradient
`6% to 7'7,. CH3CN
`
`0
`
`5
`
`TIME Cmlnl
`
`10
`
`15
`
`Figure 3. Block copolymers. Solvents a and b were used in
`eaCh at a flow rate of 3 ml/min.
`
`and thus change their elution properties. The use of pH above
`6 is not recommended because silica slowly dissolves in water
`above pH 6.
`The Microbondapak Cl8 column in combination with a single
`type of solvent, namely CH3CN/water solutions, over a very narrow
`concentration range, has proved to be a very versatile tool in
`analyzing mixtures of oligoribonucleotides. These mixtures can
`be the result of the use of biosynthetic enzymes such as poly(cid:173)
`nucleotide phosphorylase, RNA ligase, polynucleotide kinase and
`others in the synthesis of oligoribonucleotides of known sequence,
`for example, or they can be products of the activity of a variety
`
`1078
`
`12
`
`

`

`Nucleic Acids Research
`
`of nucleases on RNA, etc. The ability to analyze reaction mix(cid:173)
`tures in such short periods of time allows the study of the
`time course of these reactions in a quantitatively as well as
`qualitatively accurate manner. This could open the door to re(cid:173)
`action mechanism studies which have been limited by the cumber(cid:173)
`some and time consuming methods of product analysis previously
`available.
`There are indications that the system can be adapted to
`other uses, for example, the analysis of longer nucleic acids,
`which would be of value in the purification and sequence analysis
`of RNA and DNA. A further application should be in the separation
`of alkylated mono- and oligonucleotide products resulting from
`the action of activated carcinogens or mutagens.
`
`ACKNOWLEDGMENTS
`
`This work was supported in part by grants from the National
`Science Foundation (PCM76-04992 AOl), The National Institutes of
`Health (GU 24494), the Petroleum Research Fund (9196-G6), and
`the Research Corporation. We are grateful for helpful discussions
`with D. A. Brant, T. A. Posever 1 R. L. Boughton and applications
`personnel from Waters Corporation.
`
`REFERENCES
`1. Khorana, H. G. and Vizsolyi, J. P. (1961) :!· Am. Chem. Soc.,
`83 675.
`2. Borer, P. N., Kan, L. s. and Ts'o, P.O.P (1975)
`Biochemistry, 1ft• 4847; appendix in microfilm edition contains
`details of synt esrs-irid purification.
`3. Borer, P. N. (1972) Ph.D. Thesis, University of California,
`Berkeley.
`4. Martin, F. H. (1969) Ph.D. Thesis, Harvard University.
`5. Uhlenbeck, 0. C. (1969) Ph.D. Thesis, Harvard University.
`6.
`Leutzinger, E. E., Miller, P. S. and Ts'o, P.O.P. (1978)
`in Nucleic Acid Chemist~Improved and New Synthetic Pro(cid:173)
`cedures, MetliOcls and Tee gues • Townsencr;-L. B. , and Tips on,
`R. S. (eds.), Wiley, (1978).
`7. Walker, G. C., Uhlenbeck, O.C., Bedows, E., and Gumport,
`R. I. (1975) Proc. Nat. Acad. Sci. ~~t~ 72, 122.
`Shum. B. W. , iiiiO"Crother'S'";""D. M:""\1
`Nucleic Acids Res.
`.
`5, 2297.
`9. Hardies, S. C. and Wells, R. D. (1976) Proc. Nat. Acad. Sc1.
`USA, 73 3117.
`Egan.~ z. (1973) Biochim. Biophys. Acta, 299, 245.
`
`8.
`
`10.
`
`1079
`
`13
`
`

`

`Nucleic Acids Research
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`. , Weeren, n. , Weiss, J. F. , Pearson, R. L. ,
`
`Pearson, R. L., WEiss, J. F., and Kelmers, A. D. (1971)
`Biochim. B·iobhys. Acta, 228 770.
`ttetmers, A.
`Stulberg, M. P., and Novelli, G. D. (1971) Meth. Enzymology,
`XX Part C, 9.
`Pritz, H. J., Belagafe, R., Brown, G. L., Fritz, R. H.,
`Jones, R. A., Lees, R. G., andiChorana, H. G. (1978)
`Biochemistry, 17 1257.
`Klee, c. B. anftinger, M. F. (1967) Biochem. Biophys. Res.
`COnin., 27, 356.
`Some exceptions have been observed, however,. with e-rich
`oligomers (see text under "Block COpolymers ) .
`
`1080
`
`14
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket